Thomas' Hematopoietic Cell Transplantation 2003
DOI: 10.1002/9780470987070.ch8
|View full text |Cite
|
Sign up to set email alerts
|

Biology of Hematopoietic Stem and Progenitor Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

2004
2004
2013
2013

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(8 citation statements)
references
References 359 publications
0
8
0
Order By: Relevance
“…To date, the only known treatment for hematopoietic failure is transplantation of bone marrow cells or HSCs [26]. But blood from the placenta and umbilical cord is a rich source of HSCs, too [27].…”
Section: Discussionmentioning
confidence: 99%
“…To date, the only known treatment for hematopoietic failure is transplantation of bone marrow cells or HSCs [26]. But blood from the placenta and umbilical cord is a rich source of HSCs, too [27].…”
Section: Discussionmentioning
confidence: 99%
“…In the bone marrow microenvironment, stem cells may remain quiescent for long periods of time until they are activated for the purpose of homeostasis or tissue repair (Manz et al, 2004). Inside the bone marrow reside long-term HSCs that have the capacity for self-renewal (see Figure 1).…”
Section: Stem Cell Biology the Hematopoietic Systemmentioning
confidence: 99%
“…As HSCs differentiate, they lose the CD34 marker and acquire other biochemical markers specific to a lineage. T cells will acquire CD4 or CD8 surface markers and B cells will acquire surface immunoglobulin markers and antigenspecific receptors (Manz et al, 2004). Table 2 summarizes the biochemical markers of the various blood cells.…”
Section: Stem Cell Biology the Hematopoietic Systemmentioning
confidence: 99%
See 2 more Smart Citations